Bristol Myers Squibb Reports Strong First-Quarter Results, Driving Stock Higher
Bristol Myers Squibb (BMY) reported strong first-quarter results, driven by double-digit sales growth in its growth portfolio, leading to a more than 5% stock increase. The company's overall revenue rose 3% year-over-year to $11.5 billion, with the growth portfolio contributing $6.2 billion, while the legacy portfolio declined by 6%.
Tickers: $BMY
Topics: Earnings Pharmaceutical Industry Revenue Growth Stock Performance